This thinking capability was first introduced by Google in its Gemini 2.0 Flash Thinking Experimental AI model, which was ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions, has announced that the ...

While UK cystic fibrosis patients continue their long wait for access to Vertex’s Orkambi, the drug has received a label extension from the European Commission allowing it to be used in younger ...

Vertex Pharmaceuticals (NASDAQ ... paving the way for a potential label expansion. Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has ...

Trinasolar ( ), a global leader in smart PV and energy storage solutions, is proud to announce its participation in the Solar&Storage ...

New cases of a dangerous, drug-resistant fungus have been identified in at least two states’ hospital systems. Candida auris, also called C. auris, was first identified in the U.S. in 2016.